Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex

DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

(2011) Y. Jiao et al.   SCIENCE

Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors

(2010) Hiu-yan Chan et al.   ADVANCES IN THERAPY

Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes

(2010) Maya B. Lodish et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies

(2010) Robert T. Jensen et al.   CANCER

The Pathologic Classification of Neuroendocrine Tumors

(2010) David S. Klimstra et al.   PANCREAS

Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway

(2009) Edoardo Missiaglia et al.   JOURNAL OF CLINICAL ONCOLOGY

Perivascular epithelioid cell tumor (PEComa) of the pancreas: Immunoelectron microscopy and review of the literature

(2009) Kenichi Hirabayashi et al.   PATHOLOGY INTERNATIONAL

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

(2008) T. R. Halfdanarson et al.   ANNALS OF ONCOLOGY

Prognostic Factors and Survival in 324 Patients with Pancreatic Endocrine Tumor Treated at a Single Institution

(2008) S. Ekeblad et al.   CLINICAL CANCER RESEARCH

Pancreatic somatostatinoma and tuberous sclerosis: case report of an exceedingly rare association

(2008) Jayaprakash Sreenarasimhaiah et al.   GASTROINTESTINAL ENDOSCOPY

Cystic Pancreatic Endocrine Neoplasms: A Distinct Tumor Type?

(2008) Liliana Bordeianou et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS